isomethyleugenol has been researched along with Brachial Paresis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Broersen, LM; Dyall, SC; Feichtinger, RG; Hageman, RJ; Kofler, B; Lotstra, S; Michael-Titus, AT; Paredes-Esquivel, U; Priestley, JV; Rhodes, M; Silva, JP; Svendsen, L; Thau-Zuchman, O; Tremoleda, JL; van Wijk, N; Verkuyl, JM | 1 |
| Cohen, IJ | 1 |
2 other study(ies) available for isomethyleugenol and Brachial Paresis
| Article | Year |
|---|---|
A new ketogenic formulation improves functional outcome and reduces tissue loss following traumatic brain injury in adult mice.
Topics: 3-Hydroxybutyric Acid; Acetylation; Animals; Ataxia; Brain; Brain Injuries, Traumatic; Diet, Ketogenic; Dietary Carbohydrates; Dietary Fats; Dietary Fiber; Dietary Proteins; Disease Models, Animal; Docosahexaenoic Acids; Epigenesis, Genetic; Glycemic Index; Histone Code; Inflammation; Lameness, Animal; Leucine; Male; Methylation; Mice; Morris Water Maze Test; Oligodendroglia; Paresis; Postural Balance; Rotarod Performance Test; Sensation Disorders; Signal Transduction; Spatial Memory; TOR Serine-Threonine Kinases; Triglycerides | 2021 |
Methotrexate-associated alterations of the folate and methyl-transfer pathway in the CSF of ALL patients with and without symptoms of neurotoxicity.
Topics: Adolescent; Brain Infarction; Child; Child, Preschool; Demyelinating Diseases; Facial Paralysis; Female; Folic Acid; Humans; Male; Metabolic Networks and Pathways; Methotrexate; Methylation; Neurotoxicity Syndromes; Paresis; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2009 |